Premium
A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PROGNOSTICATORS IN MANTLE CELL LYMPHOMA: RESULTS FROM THE MCL0208 TRIAL FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)
Author(s) -
Ferrero S.,
Moia R.,
Cascione L.,
Zaccaria G. M.,
Rinaldi A.,
Alessandria B.,
Grimaldi D.,
Favini C.,
Evangelista A.,
Schipani M.,
Narni F.,
Stelitano C.,
Stefani P. M.,
Benedetti F.,
Mian M.,
Casaroli I.,
Zanni M.,
Castellino C.,
Pavone V.,
Galimberti S.,
Re F.,
Rossi D.,
Cortelazzo S.,
Gaidano G.,
Ladetto M.,
Bertoni F.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.59_2879
Subject(s) - mantle cell lymphoma , medicine , cdkn2a , oncology , lenalidomide , progression free survival , hazard ratio , univariate analysis , proportional hazards model , lymphoma , multivariate analysis , chemotherapy , cancer , multiple myeloma , confidence interval